The PDA Parenteral Packaging Conference returns to Basel for 2022! Check out an exciting program including talks from Ulla Grauschopf (Roche), Patricia Hughes (FDA), Guido Dietrich (Coalition for Epidemic Preparedness Innovations, CEPI), and Sebastian Gerner & Arne Kloke (Alliance to Zero). View the agenda for more information on sessions and speakers.

Pharmap gathers professionals and decision-makers to discuss issues and trends of the pharmaceutical industry. The business program focuses on new pharmaceutical solutions and innovations, the challenges and strategies for transformation by robotics and AI, the brand protection and start-up solutions for the pharmaceutical industry.

The 13th Global DDF Summit focuses on advances and new research in formulation and drug delivery. It provides the opportunity to hear from senior scientists and industry professionals who have recently developed and published new techniques in their fields through detailed presentations, interactive panels and roundtables – providing excellent networking opportunities. The summit has 4 main streams: small molecules, biologics, devices/combination products and tech & innovation.

The Next Generation Lipid-Based Nanoparticles Delivery Summit is your definitive industry-led meeting to design and engineer 2nd generation of lipid nanoparticles for emerging payloads beyond RNA into clinic. Join Intellia Therapeutics, Entos Pharmaceuticals, AstraZeneca, Eli Lilly, and other scientific trailblazers as they navigate the next generation of lipid-based nanoparticles for targeted delivery to expedite innovative treatments for unmet patient needs.

The drug delivery industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. That is why you cannot afford to miss Pharma Ed’s Microneedle & Transdermal Drug Delivery Forum. Leading researchers from industry and academia come together to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Connect in Pharma is a new annual event dedicated to advanced pharmaceuticals downstream from the molecule and biotechnology, designed to drive innovation, business and new partnerships in four key areas: innovative packaging; drug delivery systems; CMO/CDMO; and filling and assembly.

This conference will examine the safety, quality and regulatory issues. It will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, FDA guidances & other international regulatory requirements for best practices in materials and chemistry characterisation for drugs, biologics, delivery systems, and primary & secondary packaging.

Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing for combination products. Pharma Ed’s Combination Products Summit features expert insight into CP development and the complex quality, safety, and regulatory compliance issues facing the CP market.

SAE Media Group’s (formerly SMi) 3rd Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives.

Canna Pharma links current knowledge and practice in the pharmaceutical and cannabis industries, providing a forum for scientific dialogue and collaboration to enlarge the scope of safe and effective therapies in this growing market. Join the discussion to advance medicinal cannabis science, and network with research/discovery scientists, product developers, cultivators, processors, quality assurance professionals, and policy makers

Regulators in North America and Europe are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilisation, and aseptic process simulation (or media fill). The Aseptic Processing Summit includes expert insight into the robust aseptic processing requirements facing the industry, and covers implementation and management of best practice aseptic, barrier, containment, and aseptic technologies.

Projected to hit US$8 billion by the end of 2024 in the US alone, the market for PFS and autoinjectors continues to grow fast. Numerous advantages such as ease of administration, enhanced safety, reduced risk of contamination, and accuracy of dosing make PFS & autoinjectors attractive. Growth in the biologics market, rising preference for self-administrations which use PFS, pen injectors, and autoinjectors, are propelling the growth. This is why you cannot afford to miss Pharma Ed Resources’ Pre-filled Syringes & Auto-Injectors Forum, which brings together thought-leaders and key decision makers over two days.